| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.08 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.08 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.08 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.09 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.081 | 0.09 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.09 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.09 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.06 | 0.09 |